Scalper1 News
Big pharmas Merck (MRK) and Pfizer (PFE) modestly beat Q2 estimates early Tuesday, but their guidance remained cautious. Merck stock was up more than 1%, while Pfizer stock was up a fraction in early trading on the stock market today. Merck’s Q2 earnings totaled 85 cents a share, up a penny from the year-earlier quarter and beating analysts’ consensus by 4 cents. Sales shrank 1% to $10.9 billion due to patent losses but beat the Street’s Scalper1 News
Scalper1 News